Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Emerging Technologies in Biological Models, When and Why?

Autor: Hoffman AF; 1 GlaxoSmithKline , Collegeville, Pennsylvania., Nolan J; 2 The Scintillon Institute , San Diego, California., Gebhard DF; 3 Pfizer, Inc. , Groton, Connecticut., Nickischer D; 3 Pfizer, Inc. , Groton, Connecticut., Omta W; 4 Core Life Analytics B.V. , Utrecht, The Netherlands ., Cooper S; 5 Imperial College London, Institute of Cancer Research , London, United Kingdom ., Presnell S; 6 Organovo, Inc. & Samsara Sciences, Inc. , San Diego, California., Wardwell-Swanson J; 7 InSphero, Inc. , Brunswick, Maine., Fennell M; 8 Memorial Sloan Kettering Cancer Center , New York, New York.
Jazyk: angličtina
Zdroj: Assay and drug development technologies [Assay Drug Dev Technol] 2018 Jan; Vol. 16 (1), pp. 1-6.
DOI: 10.1089/adt.2017.29070.afh
Databáze: MEDLINE